Here are five points:
1. Canaccord Genuity currently has a $150 price target on the stock.
2. The company also has a consensus rating of “buy” from other equities research analysts.
3. Zimmer Holdings has a 52-week low of $94.73 and a 52-week high of $121.84.
4. The stock’s 50-day moving average is $113 and its 200-day moving average is $115.
5. The company has a market cap of $19.32 billion.
More articles on devices:
Russell indexes add InVivo Therapeutics — 5 key notes
Former OtisMed CEO gets 2 years in prison in knee device scandal — 5 key notes
Amedica shares shoot up 10% — 6 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
